Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia,Translational Neurodegeneration

当前位置： X-MOL 学术 › Transl. Neurodegener. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia
Translational Neurodegeneration ( IF 12.6 ) Pub Date : 2019-06-26 , DOI: 10.1186/s40035-019-0157-9
Qiao Wei ₁ , Hai-Lin Dong ₁ , Li-Ying Pan ₂ , Cong-Xin Chen ₁ , Yang-Tian Yan ₁ , Rou-Min Wang ₁ , Hong-Fu Li ₁ , Zhi-Jun Liu ₃ , Qing-Qing Tao ₁ , Zhi-Ying Wu _{1,

4}

Affiliation

Although many causative genes of hereditary spastic paraplegia (HSP) have been uncovered in recent years, there are still approximately 50% of HSP patients without genetically diagnosis, especially in autosomal recessive (AR) HSP patients. Rare studies have been performed to determine the genetic spectrum and clinical profiles of recessive HSP patients in the Chinese population. In this study, we investigated 24 Chinese index AR/sporadic patients by targeted next-generation sequencing (NGS), Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Further functional studies were performed to identify pathogenicity of those uncertain significance variants. We identified 11 mutations in HSP related genes including 7 novel mutations, including two (p.V1979_L1980delinsX, p.F2343 fs) in SPG11, two (p.T55 M, p.S308 T) in AP5Z1, one (p.S242 N) in ALDH18A1, one (p.D597fs) in GBA2, and one (p.Q486X) in ATP13A2 in 8 index patients and their family members. Mutations in ALDH18A1, AP5Z1, CAPN1 and ATP13A2 genes were firstly reported in the Chinese population. Furthermore, the clinical phenotypes of the patients carrying mutations were described in detail. The mutation (p.S242 N) in ALDH18A1 decreased enzyme activity of P5CS and mutations (p.T55 M, p.S308 T) in AP5Z1 induced lysosomal dysfunction. Our results expanded the genetic spectrum and clinical profiles of AR-HSP patients and further demonstrated the efficiency and reliability of targeted NGS diagnosing suspected HSP patients.

更新日期：2020-04-22

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>